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Rats and mice are relatively resistant  to severe anaphylactic shock and to 
large  doses  of histamine  given parenterally.  Furthermore,  methods  effective 
for producing  severe active  cutaneous  hypersensitivity in  many  species  are 
ineffective for producing skin hypersensitivity in the rat. Rats and mice treated 
with Hemophilus pertussis  vaccine show increased susceptibility to the death- 
producing  effects of  parenterally  administered  histamine,  serotonin,  and  to 
anaphylacfic shock (1, 2). 
Pertussis vaccine injected into rat skin might change the reactivity of the 
injected skin to histamine and/or serotonin; also,  skin prepared by pertussis 
vaccine might show increased reactivity to agents such as dextran and 48/80 
or to antigen-antibody complexes. To test this possibility the right dorsal paw 
skins  of rats were injected with Hemophilus pertussis  vaccine of a  type used 
for  human  immunizations.  The  vaccine  produced  an  acute  edema  which 
slowly subsided;  by 4  days all injected paws  showed only slight  edema and 
erythema. On the 5th day the injected paws became greatly swollen, red, and 
apparently painful, a reaction much more severe than that during the previous 
4 days. Serum obtained from each rat on the 5th day contained agglutinins for 
pertussis in low titer.  On  the 6th day the previously untreated left paws  of 
each rat were injected with pertussis vaccine; within  12  to 24 hours the left 
paws  became as  red,  swollen,  and  apparently painful  as  the right paws  had 
been, indicating an induced cutaneous hypersensitivity to the vaccine. 
It seemed reasonable to suspect that pertussis vaccine had altered the re- 
activity  of  skin  to  serotonin  and/or  histamine.  Possibly  the  hypersensitive 
inflammation was mediated by tissue histamine and/or serotonin released by 
pertussis antigen-antibody complexes. These speculations have not been sub- 
stantiated, but the following is a report on what we believe is the first demon- 
stration of severe active cutaneous hypersensitivity in the rat. 
Materials and Methods 
Young adult  female Sprague-Dawley rats  weighing between 200 and 250 gin. and fed 
Purina chow and water ad Ubitum were used. They were anesthetized with ether for all in- 
jections. 
* Aided in part from grants from the United States Public Health Service (Grant No. 
H-3543) and from  the Block Fund, University of Chicago. 
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A commercial Hcmophilus  pertussis  vaccine prepared for human immunization was com- 
pared with a standard Hemophilus pertussis vaccine,  l The supernatant fluid of the commercial 
vaccine produced an acute inflammation in normal rat  skin;  the supernatant fluid of the 
standard vaccine did not have this activity. Washed commercial vaccine and a  National 
Institutes of Health  standard  vaccine, washed or  tmwashed, produced similar  cutaneous 
reactions in rat skin when the vaccines contained equal numbers of organisms. In all experi- 
ments commercial vaccine, washed 3 times and suspended in sterile normal saline, was used. 
Concentrations of the vaccine were determined turbidimetrically in an electrophotometer. 
Washed vaccine resuspended in saline to contain the same number of organisms as the original 
vaccine, which was about 6 X  10  l° organisms per ml., is referred to as whole pertussis vaccine. 
Whole pertussis vaccine diluted to contain about 1.2  X  10  l° organisms per ml. is referred to 
as pertussis vaccine 1:5. Typhoid vaccine prepared for human immunizations  *  was also washed 
and resuspended in saline to contain the same number of organisms as whole pertussis vaccine 
and pertussis vaccine 1:5. 
0.2  ml. of whole pertussis vaccine injected subcutaneously in equally divided doses in a 
fore and hind paw produces severe inflammation in the injected paws in about 5 days. This 
inflammation is  referred to  as  the primary  hypersensitive  response.  If  the uninjected fore 
and hind paws of a rat which has developed a primary hypersensitive  response are challenged 
with 0.2  ml. of pertussis vaccine 1:5, severe inflammation develops in the challenged paws 
within 24  hours. This reaction is referred to as the secondary hypersensitive  response. The 
first injection of whole vaccine is  ~  considered as sensitizing the rat. 
The primary and  secondary hypersensitive responses can be elicited in  abdominal skin 
though the reactions are not as severe in the gross as in paw skin. For some experiments 
sensitizing injections of vaccine were made in abdominal skin but the secondary hypersensitive 
response was alsways elicited in paw skin because injection sites could be precisely located 
and equivalent areas of skin could be removed readily for quantitation of edema. 
In some experiments, rats were sensitized by injection of vaccine in the dorsa of the right 
fore and hind paws. In these experiments the left paws were used to test the subsequent 
response of the rat  to an agent such as pertussis vaccine, typhoid vaccine, or some other 
substance. In other experiments rats were sensitized by injection of vaccine in shaved ab- 
dominal skin. In these experiments each rat could be used to test the response to 2 agents; 
one was tested in the right paws and the other agent was tested in the left paws. 
To  measure the severity of the inflammatory reaction in the secondary hypersensitive 
response, tissue water was determined in paw skin 24 hours after challenge. The full thickness 
dorsal paw skins, from the wrist or ankle to the interdigital spaces, were carefully removed 
from exsanguinated rats. The fore and hind paw skins from one side were combined for a 
determination. Each sample, fore and hind paw skin, was weighed, dried at 72°C. for 4 days 
and reweighed; the percentage water in the sample was calculated. In the figures and tabular 
matter percentages of water in paw skins have been rounded to the nearest whole number. 
The edema-producing agents: serotonin, histamine, and 48/80, 8 and the control injections 
of saline were also tested in paws on one side of a rat; 0.2 ml. of the agent tested was injected 
in equally divided doses in a fore and hind paw. Concentrations of histamine and serotonin 
are recorded as micrograms of free base per milliliter while concentrations of 48/80 are  re- 
1  The commercial vaccine was purchased from Eli Lilly and Co., Indianapolis. The Standard 
vaccine was kindly supplied by  Dr.  Margaret  Pittman,  Division of Biologics  Standards, 
National  Institutes of Health, Bethesda, Maryland. 
2 Kindly donated by Eli Lilly and Co.,  Indianapolis. 
)  5-Hydroxytryptamine creatine sulfate  (serotouin)  and histamine dihydrochloride were 
purchased from Nutritional Biochemicals Corporation, Cleveland. 48/80 was kindly supplied 
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corded as micrograms of dry material per milliliter. Dilutions of these agents were made in 
sterile saline. The method for measuring the edema was the same as that for the vaccine 
except that the paw skins were obtained 2 hours after injection (3). 
The rats were bled for agglutinin titers from tail veins. The sera were stored at  --30°C.; 
all titrations were done at the completion of the experiment. Serial double dilutions of a serum 
were made in saline. Then an equal volume of washed pertussis or typhoid vaccine, diluted 
to contain about 9  X  109 organisms per ml., was added to each serum dilution. The tubes 
were incubated at room temperature for 2 hours and then centrifuged for 4 minutes at 2,500 
R.p.u.  The  sediment in  each tube was individually resuspended.  The agglutinin titer was 
taken as the highest serum dilution in which gross aggregations of bacterial particles had 
occurred. For averaging titers the arithmetic mean of the logarithms of titers was computed 
and this figure was converted into titer units. 
Lymph  node cells were prepared  for passive transfer tests from  popliteal and  axillary 
lymph nodes of rats whose paws had been injected with pertussis vaccine. Sterile cold Tyrode's 
solution and sterile instruments and utensils were used for these procedures. The preparation 
of cell suspensions was carried out at about 6°C.  Rats were killed by a  blow on the head. 
The nodes, carefully dissected from areolar tissue, were pooled in Tyrode's solution and finely 
minced with sharp scissors. The supernatant was filtered through coarse gauze. The sediment 
with added Tyrode's was gently ground by hand with a  mortar and pestle; the superuatant 
was  similarly filtered and added  to  the initial supernatant suspension.  The pooled  super- 
natant suspension of cells was centrifuged for 3 minutes at 1500 a.P.~. The packed cells were 
resuspended in-an appropriate volume of Tyrode's solution to give the desired number of cells 
per milliliter of suspension. 
EXPEI~ IMI~.NTAL OBSERVATIONS 
Preliminary Experiments.--After the  initial  demonstration  of  cutaneous 
hypersensitivity in the rat skin, various experiments  were designed to compare 
the  doses  and  routes  of  administration  of  the  vaccine,  and  to  measure  the 
severity of the secondary hypersensitive response  in rats challenged at various 
intervals after  sensitization.  In  each  experiment  4  or more  rats  were  used  to 
test each variable. 
0.2 ml. of whole pertussis vaccine was selected as the sensitizing dose because higher doses 
did not appear to produce greater sensitivity. Lower doses might have been used; a primary 
hypersensitive response was  observed in occasional rats injected with 0.2  ml.  of pertussis 
vaccine 1:5 and these rats challenged with pertussis vaccine 1:5 showed a  strong secondary 
hypersensitive response. 
A secondary hypersensitive response was eficited in sensitized rats with dilutions of vaccine 
higher than 1:5 but this dilution was selected because it was the lowest dilution of vaccine 
which regularly produced little gross inflammation at 24 hours in the normal rat but maximal 
inflammation in sensitized rats. 
The secondary hypersensitive response was distinctly more severe in rats that had been 
sensitized subcutaneously than in rats sensitized intravenously; this was true regardless of the 
dose  of  vaccine used  for  the  sensitization or  the  time interval  between sensitization and 
challenge. 
The secondary hypersensitive response produced by pertussis vaccine 1:5 was measured 
in rats challenged at various time intervals after subcutaneous sensitization with 0.2 ml. of 
whole pertussis vaccine. No hypersensitive response occurred in paws challenged 1 day after 
the sensitizing injection. Two of 4  rats challenged at 3  days showed a  slight response. All 754  HYPERSENSITIVITY AND  HEMOPHILUS PERTUSSIS  VACCINE 
rats showed severe secondary hypersensitive responses at 5,  7,  10,  14, and 28 days after 
sensitizing injections. The secondary hypersensitive response appeared to be most severe at 
10 and 14 days; at these times the hypersensitive  inflammation reached peak intensity 12 to 
24 hours after challenge. 
On the basis of these findings we elected to challenge rats 12 days after the 
sensitizing injection of vaccine and  to measure  the secondary hypersensitive 
response 24 hours after challenge. 
Some Gross and Microscopic Observations on the  Morphology of the Primary 
and  Secondary Hypersensitive  Response.--0.2  ml.  of  whole  pertussis  vaccine 
injected subcutaneously in equally divided doses in a fore and  hind paw of a 
normal rat produced local edema which subsided slowly over a period of 2 to 
3 days. Four or 5, occasionally 3 or 6 days after the injection, the injected paws 
became swollen, red, and warm,  Fig.  1;  the  rat limped and guarded  the in- 
flamed  paws.  This  inflammation  of  the  primary  response  developed  quite 
rapidly reaching peak intensity over a period of 12 to 24 hours. Subcutaneous 
hemorrhage, necrosis, and sloughing of the dorsal skin occurred occasionally. 
The inflammation was severe for 4 to 6 days, and it subsided slowly so that by 
15 to 20 days only a firm subcutaneous nodule, 1 to 3 ram. in diameter, remained. 
Histologic sections  of paw  skin  5  days  after the  injection of whole vaccine 
showed dilatation of vessels, severe edema, and intense infiltration of the dermis 
and subcutaneous areolar tissue by leukocytes including lymphocytes, plasma 
cells,  and a few polymorphonuclear leukocytes, Fig. 3. A small central abscess 
consisting of cellular debris surrounded by polymorphonuclear leukocytes was 
seen in some sections. Paw skin taken at the time of the peak inflammation 
contained 8 to 12 per cent more water than normal paw skins. 
0.2 ml. of pertussis vaccine 1:5 injected subcutaneously in equally divided 
doses in a fore and hind paw of a normal rat produced a minimal acute edema 
which became inconspicuous in  the  gross at  24 hours.  Histologic sections of 
skin 24 hours after injection of vaccine of this concentration showed a  slight 
edema and an infiltrate of mononuclear leukocytes, Fig. 4. When a rat sensitized 
12 days previously with whole vaccine was challenged with pertussis vaccine 
1:5,  severe inflammation developed in the challenged paws within 24 hours. 
The inflammation was as severe in the gross as that of the primary response 
at  5  to  6  days.  Histologic  sections  taken  24  hours  after  challenge  showed 
marked  dilatation  of vessels  and  severe edema,  Fig.  5;  the  edematous  sub- 
cutaneous  tissues  contained  many  leukocytes,  though  these  cells  were  less 
numerous than in the primary response. Paw skins showing a severe secondary 
hypersensitive response contained 7 to 10 per cent more water than paw skin 
of normal rats injected 24 hours previously with pertussis  vaccine 1:5.  Paw 
skins injected with pertussis vaccine can be compared with normal paw skin, 
Fig. 2. 
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Pertu3sis Vaccine as an "Adjuvant".--Pertussis vaccine has been shown to act 
as an "adjuvant" in sensitizing rats to anaphylactic shock (4). It seemed rea- 
sonable to find out whether pertussis vaccine mixed with another antigen would 
produce cutaneous hypersensitivity to a  second antigen. For this experiment a 
particulate antigen, typhoid vaccine, was used. 
Forty-eight rats were divided into 4 groups of 12. The right paws of rats in group I were 
injected with 0.2 ml. of whole pertussis vaccine. The right paws of rats in group II were 
injected with 0.2 ml. of whole typhoid vaccine. Rats in group III received no injections. In 
group IV 6 rats were injected in the right paws with 0.4 ml. of a mixture of equal parts of 
whole pertussis vaccine and whole typhoid vaccine; the remaining 6 rats received 0.2 mi. of 
whole pertussis vaccine in the right paws and 0.2 ml. of whole typhoid vaccine in the left 
paws. Twelve days later, 6 rats in each of groups I, II, and III were challenged in the left 
paws with pertussis vaccine 1:5; the other 6 rats in each of these groups were challenged in 
the left paws with typhoid vaccine 1:5. All rats in the fourth group were challenged in the 
left paws with typhoid vaccine 1 : 5. The rats were sacrificed 24 hours after challenge and the 
paw skins were removed for water determinations. 
The results, presented in Text-fig. 1, show the water determinations for each 
rat plotted as  a  dot;  the  solid bar represents the  mean for similarly treated 
animals. Pertussis vaccine 1:5 produced severe inflammation in rats sensitized 
with  whole  pertussis  vaccine  but  not  in  rats  injected  with  whole  typhoid 
vaccine. Neither pertussis nor typhoid vaccine 1:5 produced inflammation in 
rats previously injected with typhoid vaccine. Typhoid vaccine 1:5 produced 
severe inflammation in rats  sensitized with a  mixture of whole pertussis and 
typhoid vaccine but not in rats  which received the  two vaccines in opposite 
paws. In the following experiment this "adjuvant" activity of pertussis vaccine 
was tested using soluble antigens. 
Sensitization of Rats to Human and Rabbit Gamma Globulin.--A preliminary 
experiment demonstrated that sterile human serum produced a  severe inflam- 
mation in the paws of rats sensitized with a  mixture of pertussis vaccine and 
human serum but not in rats injected with human serum alone. The following 
experiment was designed to give some information about the specificity of the 
reaction using more homogeneous soluble antigens. 
Human gamma globulin, 120 mg./ml., was mixed with an equal volume of whole pertussis 
vaccine. Each of 6 rats was injected subcutaneously in the abdominal skin with 0.8 ml. of 
the mixture given in 4 equal depots. A second group of 6 rats was treated  similarly except 
that each rat received rabbit gamma globulin and pertussis vaccine in the same volume and 
concentration as the first group. Thus, each rat received a total of 0.4 ml. of whole pertussis 
vaccine (twice the usual dose) and 48 mg. of either human or rabbit gamma globulin. Twelve 
days later the right paws of all rats were each challenged with 0.1 ml. of a solution containing 
60 mg./ml, of human gamma globulin and the left paws were challenged with a similar volume 
and concentration of rabbit gamma globulin. Paw skins were taken for water determinations 
24 hours after challenge. (Paw skins of normal rats challenged with this volume and concen- 
tration of human or rabbit gamma globulin contain about 70 per cent water 24 hours after 
the injection.) 756  HYPERSENSITIVITY  AND  ]~rEMOPHIL~SS  PERTUSSIS  VACCINE 
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The results are presented in Text-fig. 2. Human gamma globulin produced 
severe inflammation in 4: of 6 rats sensitized with pertussis vaccine and human 
gamma globulin but it did not produce an appreciable response in rats sensi- 
tized to pertussis vaccine and rabbit gamma globulin. Similarly, rabbit gamma 
globulin  produced severe inflammation in  4  of 6  rats  sensitized  to pertussis 
vaccine and rabbit  gamma  globulin  but it  did  not produce a  significant re- 
sponse in rats sensitized to pertussis vaccine and human gamma globulin. The 
"adjuvant" action of pertussis vaccine appeared to be similar for the particulate 
antigen,  typhoid vaccine,  and  for these  two  soluble  antigens.  Furthermore, 
the sensitization appeared to be specific for the antigen added to the pertussis 
vaccine. 
It is of interest that in other experiments using soluble antigens some of the 
rats injected with pertussis vaccine and antigen in separate depots developed 
cutaneous hypersensitivity to the soluble antigen.  This is in  contrast to our 
findings with the particulate antigen, typhoid vaccine, and could be explained 
by  the  fact  that  soluble  antigen  enters  the  circulation  more  readily  than 
particulate  antigen.  Circulating  soluble  antigen  may localize  at  the  site  of 
focal acute inflammation produced by whole pertussis vaccine in normal rats. 
By this means at least some soluble antigen may be "mixed" with pertussis 
vaccine.  This  same  phenomenon may occur in  anaphylactic sensitization  in 
mice when pertussis vaccine and antigen are given by different routes (5). 
Agglutinin  Response of the Rat to Pertussis and/or Typhoid  Vaccine.--This 
experiment was designed to study the circulating agglutinin response to per- 
tussis vaccine and to see if pertussis vaccine, added to typhoid vaccine, affected 
the circulating agglutinin titers for typhoid vaccine. 
Eighteen rats were divided into 3 groups of 6, and all animals were bled for baseline fiters. 
The right paws of one group were injected with 0.2 ml. of whole  pertussis vaccine, and second 
group with 0.2 ml. of whole typhoid vaccine, and the third group with 0.4 ml. of a mixture of 
equal parts of whole pertussis vaccine and whole typhoid vaccine. All rats were bled at 6, 10, 
14, 22, and 28 days after the injections. The serum from each animal for each bleeding was 
titrated for agglutinins to typhoid and to pertussis vaccines. The results, plotted in Text-fig. 
3, are for the mean titers of each group of 6. 
Rats injected with pertussis vaccine did not produce measurable agglutinins 
for typhoid vaccine; similarly rats injected with typhoid vaccine did not pro- 
duce measurable agglutinins to pertussis vaccine. Rats injected with the mix- 
ture of vaccine did not respond with higher agglutinin  titers  to pertussis  or 
typhoid than animals receiving pertussis or typhoid vaccine alone. 
The antibody response to  typhoid vaccine, with peak  titers  6  to  24 days 
after immunization, is typical of the response of the rat to various bacterial and 
particulate red  cell antigens  given v/a different routes of administration  (6). 
The delayed antibody response to pertussis vaccine with peak titers 3 weeks 
after immunization is  unusual;  in  this  experiment differences in mean  titers 7~8  ]~YPERSF.NSITMTY  AND  HEMOPIIILUS  PERTUSSIS  VACCINE 
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between the 10th and 22nd day are not great but all 12 rats had as high or 
higher titers on the 22nd day as on the 10th and 14th day. A delayed antibody 
response  to pertussis  vaccine has been  observed in other experiments using 
larger dosages of antigen and other routes of administration; for example, 1.0 
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TF.xT-Fto. 3. Antibody  response of rats immunized  with pertussis and/or typhoid vaccine. 
ml. of whole pertussis vaccine given intravenously produced peak titers on the 
28th day or later. 
The results of the titrations for circulating antibody did not indicate whether 
circulating agglutinins to pertussis  vaccine play a  role in the hypersensitive 760  HYPERSENSITIVITY  AND  HE~OPHILUS  PERTUSSIS  VACCINE 
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response.  However,  the  failure  of  pertussis  vaccine  to  affect  the  agglutinin 
response to typhoid vaccine in rats sensitized to the mixture of vaccines sug- 
gested  that  agglutinins to  whole  typhoid vaccine did not  play a  role in  the 
hypersensitive  response  to  typhoid  vaccine.  Passive  transfer  experiments 
were undertaken to study the role of serum antibody and of lymph node cells 
in the hypersensitive response. 
Passive Transfer of Skin H~persensitivity to Pertussis Vaccine.--Passive  trans- 
fer of the cutaneous hypersensitive response  was  attempted  in  a  series of ex- 
periments using serum flom hypersensitive donor rats. 
Sera were obtained at various times from 6 to 28 days after sensitization. Some of the sera 
contained high and others low aggiutinin titers for pertussis vaccine.  In some experiments 
the sera were injected into normal recipient rats in volumes from 1.0 to 6.0 ml. intravenously 
and/or intraperitoneally; in other experiments sera were injected into paw skin in volumes 
from 0.05 to 0.2 ml. per paw. Paws of recipient rats were challenged with pertussis vaccine 
variously 24 hours prior to, at the time of, or 24 hours after giving the serum. Passive transfer 
of skin hypersensitivity with serum was not observed in a single instance in any experiment. 
In contrast to our findings with "immune" serum, we have passively trans- 
ferred  skin hypersensitivity by'using  lymph  node  cells from  sensitized  rats. 
This  passive  transfer  of  hypersensitivity has  been  accomplished  by  several 
methods  including  the  injection  of  lymph  node  cells  intravenously,  intra- 
peritoneally, or into the skin which is challenged with vaccine. With the latter 
method, the cells can either be mixed with the vaccine, or given 24 hours prior 
to or 24 hours after challenge with the vaccine. Local passive transfer has given 
the most uniform results and is relatively economical of donor cells. 
In one experiment twelve donor rats were prepared by injecting all four paws With whole 
pertussis vaccine, 0.2 ml. per paw. Fourteen days later each paw was again injected with 0.1 
ml. of whole pertussis vaccine. Five days after the second injection the rats were sacrificed, 
and a  lymph node cell suspension  was prepared from pooled popliteal and axillary lymph 
nodes. Fifteen normal recipient rats were divided into groups I and II each containing 6 rats 
and group HI containing 3 rats. The right paws of all rats in group I and II were  injected 
with 0.1 ml. of pertussis vaccine 1:5 and the left paws with 0.1 ml. of typhoid vaccine  1:5. 
The right and left paws of rats in group III were injected with saline. Twenty four hours later 
the right and left paws of rats in groups I and III were injected with 0.1 ml.  of fresh lymph 
node cell suspension containing  5 X  108 eells/ml.; the right and left paws of rats in  group 
II were injected with saline. Twenty four hours after injection of lymph node cells paw skins 
were obtained for water determinations. The results are presented in Text-fig. 4. 
Paw skins injected with pertussis vaccine and lymph node cells were severely 
inflamed and contained about 80 per cent water; paw skins injected with lymph 
node cells and typhoid vaccine, lymph node cells alone, or vaccine alone showed 
little or no  gross inflammation and  contained  about  70  per  cent  water.  Ap- 
parently the hypersensitive response of the rat to pertnssis vaccine is similar 
to  delayed  or  tuberculin  type  hypersensitivity studied  extensively in  other 762  HYP]~RSENSITIVITY  AND  HEMOPHILUS  PERTUSSIS  VACCINE 
species,  in  that  hypersensitivity can  be  transferred  with  cells  but not with 
serum (7, 8). 
Cutaneous  Reactivity  of  Pertussis  Sensitized  Rats  to  Histamine,  Serotonin 
or  48/80.--In  preliminary experiments  we  found  that  rats  injected  subcu- 
taneously with 0.2  to 0.4 ml. of whole pertussis vaccine showed 6  to  14 days 
later  increased  susceptibility to  death  when  challenged  intravenously  with 
large dosages of histamine. Possibly the cutaneous hypersensitivity to pertussis 
vaccine might be related to increased cutaneous reactivity to histamine and/or 
other agents which produce edema in rat skin. 
TABLE I 
The Cutaneous Reactivity of Sensitized  and Non-Sensitized  Rats to Edema-Producing Agents 
~on-sensitized 
controls 
~ensitized  to 
pertussis vac- 
cine 
Range for 6 deter- 
minations. 
Average  ..... 
Range for 6 deter- 
minations .... 




































Accordingly,  21 rats were each injected in the abdominal skin with 0.4 ml. of whole pertussis 
vaccine given in four equal depots. A second group of 21 rats received no injections. Twelve 
days later 6 rats in each group were challenged intravenously with 75 rag. of histamine. Four 
of 6 sensitized rats died within 2 hours; none of the 6 normal controls died within 24 hours. 
The remaining 15 animals in each group were handled in the following  manner: The right  or 
left paws of 6 rats in each group were challenged with pertussis vaccine 1:5, and 22  hours 
later the right or left paws, not challenged with pertussis vaccine, were injected with histamine 
(100 #g./ml.), serotonin (0.5 #g./ml.), or saline. These doses of serotonin and histamine were 
selected because they produce an increase in tissue water of about 5 per cent.  Doses of these 
agents twofold greater produce about a 10 per cent increase in tissue water but larger dosages 
do not produce more edema in paw skin which is sampled for water determinations. Therefore, 
under these conditions any slight increased reactivity produced by sensitization should be 
measurable. The response produced by each agent was measured 6 times in each group of 
rats; the response to pertnssis vaccine was measured 24 hours after challenge while the response 
to the other agents was measured 2 hours after challenge. 
A  summary of the results is presented in Table I.  It is apparent that rats 
sensitized to pertussis vaccine do not show increased cutaneous reactivity to the 
edema-producing activity of histamine, serotonin, or 48/80.  This is in sharp 
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intravenously.  This  experiment  did  not  exclude  the  possibility  that  tissue 
histamine  and/or  serotonin  were  important  in  the  mediation  of  cutaneous 
hypersensitivity in rats sensitized to pertussis vaccine. 
The Role.of Histamine and~or Serotonin in the Mediation of Cutaneous Hyper- 
sensitivity  in the Rat.--Inflammation  in rat skin mediated by tissue serotonin 
and histamine (a) are associated with damage to mast cells, (b) are inhibited by 
specific blocking agents for serotonin and histamine,  and  (c)  are inhibited in 
tissues "depleted" of mast cells. 
The  morphology of  mast  cell  damage  was  studied  in  the  following  way. 
Paws of 18 sensitized and  18 non-sensitized rats were challenged with pertussis vaccine 
1:5, 48/80 (5/~g./ml.),  or saline. At 2, 6, and 24 hours after challenge, 6 sensitized and 6 
non-sensitized rats were killed; thus, 4 paw skins challenged with pertussis, 48/80 or saline 
were obtained at each time interval. Paw skins were fixed in a mixture of ethanol 80 per cent 
and neutral  formaldehyde 4 per cent; sections were stained with toluidine blue. 
48/80 produced severe mast cell damage with extensive spillage of granules 
into the edematous areolar tissue.  The damage was most apparent at 6 hours 
but  still  very evident  24 hours  after injection  of 48/80.  Equivalent  damage 
was produced by 48/80 in sensitized and non-sensitized rats. Pertussis vaccine 
1:5 produced damage to only a few mast cells in and adjacent to vaccine pools; 
damage  to  mast  cells  was  equivalent  in  sensitized  and  non-senitized  rats. 
Pertussis  vaccine  produced  only  slightly  greater  damage  to  mast cells  than 
saline. 
Dibenamine inhibits  the edema produced by serotonin; pyrilamine inhibits 
the edema produced by histamine,  and the edema produced by agents which 
damage mast cells is inhibited  by the treatment of rats with both drugs  (3). 
Twelve of 24 rats sensitized by the injection of whole pertussis vaccine in abdominal skin 
were injected with dibenamine (8 mg./kg.) and pyrilamine (16 mg./kg.); half of the dose of 
each drug was given intravenously and the other half intraperitoneally. Fifteen minutes after 
the drugs were given, the right paws of the treated and untreated rats were challenged with 
pertussis vaccine 1:5. At 4 hour intervals the treated  rats were injected  intraperitoneally 
with dibenamine (8 mg./kg.) and pyrilamine (16 mg./kg.). Four treated and 4 untreated  rats 
were challenged in the left paws with 48/80 (1/~g./ml.) at 3, 11, and 23 hours. 
These injections demonstrated  that the dosages of drugs were sufficient to 
block the formation of edema by 48/80 during the 24 hour period. At 24 hours 
all paws challenged with pertussis vaccine showed severe inflammation;  water 
determinations  showed  equivalent  secondary  hypersensitive  responses  for 
treated and untreated rats. In another experiment similar results were obtained 
using BOL-148, which is claimed to be a more specific anti-serotonin agent than 
dibenamine. 
The demonstration that the hypersensitive response could not be blocked by 
appropriate drugs and that mast cells are not damaged in the inflamed tissues 764  HYPERSENSITIVITY  AND  HE~OPHILUS PERTUSSIS VACCINE 
strongly suggested that neither histamine nor serotonin played an important 
role in the mediation of the reaction. However, to obtain additional evidence, 
the secondary hypersensitive response was compared in sensitized rats and in 





<  6  3= 
t=J 
:  5  u3 
03 
I..- 
z  4 
hJ 
¢n  3 
t~J  n- 
o 
z  2 
~e  i 
m 
SENSITIZATION PERTUSSIS  PERTUSSIS  PERTUSSIS  NONE 
TREATMENT  NONE  48/80  X-RAY  NONE 
•  PERTUSSIS  []  HISTAMINE  []  48/80 
TzxT-F1o. 5.  Edema produced by pertussis vaccine 1:5 in sensitized rats and sensitized 
rats treated  with 48/80 or x-irradiation. Edema produced by histamine (200/~g./ml,)  and 
48/80 (2.0/zg./ml.)  in sensitized and non-sensitized rats, and in sensitized rats treated with 
48/80 or x-irradiation. Differences between mean increase in tissue water greater than 3.03 
per cent are significant with a P value <0.01 when comparing responses based on the same 
controls. 
in x-irradiated rats  to  determine whether  this form of  injury depressed  the 
pertussis-hypersensitive inflammation in  the  skin  as  it  may  in  delayed  or 
tuberculin type hypersensitivity (9). 
Thirty six rats were sensitized by the injection of 0.2 ml. of whole pertussis vaccine in the 
abdominal skin. The sensitized rats were divided into three groups: Group I contained  18 
controls, group II consisted of 9 rats treated with 48/80, and group III consisted of 9  rats D.  A.  ROWLE¥~ J.  CHUTKOW~ AND  C.  ATTIG  765 
which were x-irradiated. Group IV contained 24 non-sensitized, non-treated controls. Each 
rat in group II received  a total of 3 rag. of 48/80 given intraperitoneally in increasing doses 
twice dally from days 6 to 11. Each rat in group III received  500 r total body irradiation on 
the 9th day.  * On the 12th day the right or left paws of 12 rats in groups I and IV and 6 rats 
in groups II and III were  challenged with pertussis vaccine 1:5. Twenty-two hours later 
uninjected paws of rats in groups I, II, and III were challenged with either histamine (200 
#g./ml.) or 48/80 (2 #g./ml.). The uninjected  paws of group IV were challenged with histamine 
(200 #g./ml.) 48/80 (2 #g./ml.) or saline. In group I pertussis vaccine, histamine and 48/80 
were each tested in 12 different rats; in groups II and III they were each tested in 6 different 
rats; in group IV these agents and saline were each tested in 12 different rats. Twenty four 
hours after challenge with pertussis vaccine 1:5 and 2 hours after challenge with histamine, 
48/80 or saline, paw skins were obtained for water determinations. 
The  results  are  recorded  in Text-fig.  5.  The  edema  produced  by pertussis 
vaccine in groups I, II, and III is recorded as the increase in tissue water above 
that found for pertussis vaccine in the paw skins of non-sensitized rats in group 
IV. The edema produced by histamine and 48/80 is recorded as the increase in 
tissue water above  that found for saline in group IV. The results show  again 
that sensitized rats do not respond to histamine or 48/80 with more edema than 
non-sensitized controls.  Rats  treated  with  48/80  have  a  reduced  response  to 
48/80  but  not  to  histamine  or  pertussis  vaccine.  In  contrast  the  irradiated 
rats respond normally to 48/80 and histamine but show a  significant reduction 
in response to pertussis vaccine. With our methods of measurement we failed 
to  demonstrate  that  tissue  histamine  and  serotonin or  an  altered  reactivity 
to  these  agents  played  an important  role  in  the  inflammation of  the  hyper- 
sensitive response to pertussis vaccine. 
Statistical  Note* 
Data were analyzed according to the method of the s test. Confidence limits as noted in 
the titles of the text-figures were calculated from values of t selected  at P  of 0.01, entering 
the t table at values of n appropriate for each experiment. The over-all standard deviation 
and the confidence limits based on the t distribution at a P  value of 0.01 for the data pre- 
sented in text-figures were:-- 
Text-fig. 1 ................................... 
Text-fig. 2 ................................... 
Text-fig. 4 ................................... 












* Prepared by Mr. Richard Tracy; it is a pleasure to acknowledge his help in analyzing 
the data. 
:[ The confidence limit for Text-fig. 5 can be applied only to groups using the same controls. 
4 The radiation factors were: 250 kvp, 30 ma., 0.5 ram. Cu, and 1 ram. A1 added  filtra- 
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DISCUSSION 
The  experiments demonstrate that rats  treated with pertussis vaccine de- 
velop  severe cutaneous hypersensitivity to pertussis  vaccine and  to at  least 
some particulate or soluble antigens mixed with pertussis vaccine. Tuberculous 
rats or rats injected with large doses of killed tubercle bacilli show little or no 
cutaneous hypersensitivity to tuberculin (10, 11). It is of interest that tubercu- 
lin injected into the foot-pad of C-57 black mice infected with tubercle bacilli 
produced painful reddened feet swollen to about twice normal thickness;  the 
reactions reached maximum severity at about 24 hours (12).  Though the cu- 
taneous hypersensitive response to pertussis is similar in several respects to the 
delayed or  tuberculin  type  of  hypersensitivity in  other  species,  we  do  not 
believe it is desirable to attach a  label to the reaction to pertnssis vaccine in 
the rat at this time. 
There is no question that treatment of some strains of mice and rats with 
pertussis  vaccine  increases  the  host's  sensitivity  to  histamine  given  intra- 
venously or intraperitoneally, to serotonin given by the same routes, and to 
various toxins and stresses. These effects have been discussed by Pittman (1) 
and more recently by Munoz et  al.  (2).  Pertussis-treated rats following ana- 
phylactic shock show degranulation of their mast cells  and increased plasma 
histamine; nevertheless, the role of histamine in producing anaphylactic shock 
in the pertnssis-treated rat is questioned (13).  Similar doubts were expressed 
by Malkiel in earlier studies (4).  In the present studies neither histamine nor 
serotonin has been implicated in the mediation of the cutaneous hypersensitive 
response.  Since  neither  histamine  nor  serotonin  produces  more  cutaneous 
edema in sensitized rats than in non-sensitized rats, it would appear that it is 
not altered reactivity to  these agents which accounts for the hypersensitive 
reaction. 
Some investigators have found that pertussis vaccine acts as an adjuvant; 
in mice circulating antibody titers were  1 to 3 double dilutions higher for an 
antigen when it is mixed with pertussis vaccine (14,  15). The adjuvant action 
of  pertussis  vaccine  in  enhancing  circulating  antibody  titers  has  not  been 
implicated as important in increasing either the host's resistance to infection 
(14)  or enhancing gross anaphylaxis (5,  15). Antibody is necessary for gross 
anaphylaxis,  but  studies  on  passive  anaphylaxis  in  pertussis-treated  and 
control mice clearly indicate that treatment with pertnssis vaccine produces 
an increased reactivity or sensitivity to antigen-antibody complexes separate 
from any action it may have on antibody formation (2).  In our experiments 
pertussis vaccine did not enhance measured circulating antibodies to typhoid 
vaccine; we could not passively transfer the cutaneous hypersensitive response 
with serum. Furthermore, rats injected with pertussis and typhoid vaccine in 
separate depots did not show cutaneous hypersensitivity to typhoid vaccine. 
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could not be produced in pertussis-treated rats. Thus, our studies do not sug- 
gest how pertussis vaccine profoundly alters the rat's response to antigens. 
Do laboratory investigations using pertnssis vaccine in rats and mice have 
any bearing on the study of human  pathology? Others  have suggested  that 
some cases of limb paralysis,  encephalopathy, or fatal  anaphylaxis following 
pertnssis vaccination may occur because pertussis vaccine has activity in man 
similar  to that in rats and mice  (16,  17).  At present pertnssis vaccine is in- 
corporated with two or three other antigens for human immunizations.  It is 
assumed that pertussis vaccine either has no effect on, or it enhances the im- 
munogenicity of, the other antigens.  Extensive clinical experience with triple 
vaccines indicates that no adverse effects occur in the vast majority of immunized 
individuals.  But possibly clinical studies would not detect whether some in- 
dividuals,  following  infection  or  immunization  with  Hemophilus  pertussis, 
develop sensitivity  to  an  antigen  not  "mixed"  with  the  vaccine.  It  would 
seem to be of considerable theoretical and practical importance to find out if 
this  does  occur.  Obviously,  the  human  being  cannot be  tested  by systemic 
shocking  with  intravenous  histamine  or  antigens.  Our  studies  with  the  rat 
indicate that measurement of circulating antibody or measurement of cutaneous 
edema produced by histamine will  not demonstrate altered reactivity of the 
host to pertussis organisms or to another antigen the host is exposed to at the 
time of immunization. The present studies suggest a  feasible approach to the 
clinical study of this problem in man. By using skin test techniques in properly 
designed  clinical  studies  in  selected individuals  it  should  be  possible  to  de- 
termine  whether  Hemophilus  pertussis  organisms  are a  naturally  occurring 
"adjuvant" for man. 
SUMMARY 
Itemophilus pertussis  vaccine injected into normal  rat  skin produced local 
edema  lasting  several  days.  Four  to  6  days  later  the  injected  site  became 
severely inflamed.  When  uninjected  skin  was  challenged 5  to  28  days after 
the  initial  injection,  severe  inflammation  developed at  the  site  of challenge 
within 12 to 24 hours. This secondary hypersensitive response was elicited by a 
dose of vaccine which produced little or no initial or delayed inflammation in 
a  normal  rat.  Specific  cutaneous  hypersensitivity  to  a  particulate  antigen 
(i.e. typhoid vaccine) or a  soluble antigen (human or rabbit gamma globulin) 
developed when rats were injected with a mixture of the antigen and pertussis 
vaccine. Pertussis vaccine mixed with typhoid vaccine did not enhance circu- 
lating  agglutinin  formation  to  typhoid  vaccine.  Cutaneous  hypersensitivity 
to pertussis vaccine was passively transferred to normal rats by lymph node 
cells but not with serum from hypersensitive rats. Sensitization with pertussis 
vaccine did not enhance the edema-producing activity of histamine, serotonin, 
or 48/80 given subcutaneously. Mast  cells in areas of hypersensitive inflam- 768  HYPERSENSITIVITY  AND  HEMOPHILUS  PERTUSSIS  VACCINE 
mation were not damaged appreciably. The hypersensitive inflammation was 
not  inhibited  by  treatment  with  anti-serotonin  and  antihistaminic  drugs. 
Hypersensitive  rats  "depleted  of  mast  cells"  responded  to  challenge  with 
pertussis  vaccine with  severe  inflammation  though  their  response  to  48/80 
was depressed. Hypersensitive rats treated with x-irradiation showed decreased 
hypersensitive inflammation  though  they  responded  normally  to  48/80  and 
histamine. 
These studies failed to demonstrate a  role for circulating antibody in  the 
cutaneous  hypersensitive  inflammation  produced  in  the  rat  by  pertussis 
vaccine. Furthermore, the findings indicated that the cutaneous hypersensitive 
inflammation is not mediated by tissue serotonin and/or histamine. 
The authors wish to express their appreciation for the technical assistance of Mrs. Ruth 
Daley. 
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EXPLANATION OF PLATES 
PLATE 63 
FIG. 1. Gross inflammation of a right hind paw injected 5 days previously with 0.1 
mh whole pertussis vaccine.  ×  2.5. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  110  PLATE  63 
(Rowley et al. : Hypersensitivity and Hemophilus  pertu~sis  vaccine) PLATE 64 
FIG. 2. Full  thickness  normal dorsal  paw skin stained  with hematoxylin  and eosin. 
X  105. 
FIG. 3.  Full thickness dorsal paw skin 5 days after injection with whole pertussis 
vaccine. Shows  severe edema and intense cellular infiltrates in the dermis.  Stained 
with hematoxylin and eosin.  ×  105. 
FIG. 4. Full thickness dorsal paw skin of a normal rat taken 24 hours after injection 
of pertussis vaccine 1:5.  Shows  slight thickening of the dermis by an inflammatory 
exudate.  Stained with hematoxylin and eosin.  X  105. 
FIG. 5. Full thickness dorsal paw skin of a hypersensitive rat taken 24 hours after 
injection of pertussis vaccine 1:5. The inflammatory exudate is much greater than in 
Fig. 4.  Stained with hematoxylin and eosin.  ×  105. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  110  PLATE  64 
(Rowley et al.: Hypersensitivity and  Hemophilus  pertussis vaccine) 